On Friday, April 1, 2022 the Oregon Health Authority (OHA) released revised proposed Oregon Administrative Rules (OARs) for psilocybin services. These rules focus on psilocybin products, testing, and training programs. There will be public hearings on these rules on April 18 and April 21, 2021.

In part one of this series, we covered the rules related to psilocybin products. This post will focus on rules related to testing, and part three will focus on rules related to training programs. Readers of this blog will recall we reviewed an early draft of these administrative rules on testing back in February.

This post will summarize the rules by referencing each rule by number, but you can see the exact text of each rule here.

OAR 333-333-7010

Here, the OHA explains the purpose of this section. The “testing” rules do not cover written exams on psilocybin topics. Rather, these rules establish minimum compliance testing standards for psilocybin products. In other words, a psilocybin product must undergo laboratory testing to determine if it actually contains psilocybin, the potency of psilocybin in the product, and if it is safe for human consumption.

OAR 333-333-7020

Manufacturers are responsible for ordering tests of the products they wish to sell.

Before a lab can take samples and perform tests, the manufacturer must provide the lab with it’s license number, endorsement type, name, address, and contact information. See part one for a discussion on endorsement types. Further, the manufacturer must specify to the lab the type of psilocybin product, which batches will be sampled, from which harvest lot the batches derive, from which process lot the batches derive, the total mass or volume of each batch, and which tests need to be conducted. This information all correlates with the Psilocybin Tracking System mentioned in part one.

After passing a test, the manufacturer may sell that product for one year. If a product fails a test, it may be resampled and retested. But the manufacturer must provide the lab documentation of the failed test.

OAR 333-333-7030

The OHA only allows one species of fungi for psilocybin products, which is Ppsilocybe cubensis. The first harvest of the year is required to undergo “specification testing,” ensuring the harvest only contains Psilocybe cubensis. After the initial test, the manufacturer must order monthly tests for the harvest lot to ensure there are no other fungal species. Additionally, manufacturers must order tests upon written request by the OHA.

If a batch fails this test, the manufacturer will have to test every harvest lot for twelve months to ensure there are no other fungal species.

OAR 333-333-7040

Potency generally means the amount of psilocybin found in a given product. Unlike specification testing, which involves monthly testing of the harvest, each of a harvest batch requires potency testing. Products may not exceed 20% psilocybin. Similar to specification testing, additional potency tests are required upon written request by the OHA.

OAR 333-333-7050

As mentioned in part one, some manufacturers will use solvents to extract psilocybin to make products. If a manufacturer uses methanol or acetic acid as a solvent, every process lot of psilocybin extract requires testing. If a batch has to much of either solvent, and fails the test, it can be remediated and retested. Additional solvent tests are required upon written request by the OHA.

OAR 333-333-7060

Under OAR 333-333-2040, discussed in part one, manufacturers are strictly prohibited from using pesticides for psilocybin production. Upon written request by the OHA, manufacturers must submit one or more batches for pesticide testing. A batch that fails this test must be destroyed.

OAR 333-333-7070

Under OAR 333-333-2010, discussed in part one, manure is prohibited in psilocybin production. Similar to pesticide testing, manufacturers must submit one or more batches for pesticide testing upon written request by the OHA. If any fecal matter is found in a batch, it must be assessed for E. coli and possibly aflatoxins and other mycotoxins. A batch that fails this test must be destroyed.

OAR 333-333-7080

Upon written request by the OHA, manufacturers must submit one or more batches to test for heavy metals. The heavy metals which cause a batch to fail a test are Lead, Cadmium, Arsenic, and Mercury. A batch that fails this test must be destroyed.

OAR 333-333-7090

A “batch” of psilocybin is one kilogram of dried whole fungi, or a process lot for psilocybin extracts, homogenized fungi, or psilocybin edibles.

Manufacturers must give each batch a unique number, which may not be reused. The number must be documented and maintained for three years.

OAR 333-333-7100

Testing requires an adequate sample from the batch being tested, and sample requirements are different for each type of product.

For whole fungi, the sample must be dried and represent 2% of the batch. Samples of psilocybin extracts, homogenized fungi, and edibles must be taken from the finished psilocybin product.

The sample amount and increments must be enough to undergo all required tests, and only taken by individuals employed by a laboratory with an ORELAP accredited scope item for sampling. However, the sampling may occur either on the manufacturer’s premises or the at lab.

OAR 333-333-7110

After a sample is taken, but before it is tested, the manufacturer must adequately label the batch. The label must include all identification numbers, the name of the lab that took the samples, the name of the lab conducting the testing (if different), the date the samples were taken, and in bold, capital letters, no smaller than 12-point font, “PRODUCT NOT TESTED.”

If the sample passes the tests, it may be sold!

If the sample fails the test, the manufacturer must comply with the next rule.

OAR 333-333-7120

When a sample fails a test, the lab may reanalyze the sample, but no other lab may reanalyze. For reanalysis, the manufacturer may request one within seven days, and the reanalysis must occur within thirty days of the request. If a batch passes upon reanalysis, it must be tested by another lab to confirm it passes testing. All requests for reanalysis and retesting must be disclosed to the OHA.

A batch that failed the solvent or potency tests may be fixed and retested. If a batch is remediated or destroyed after failing a test, the manufacturer must document those procedures. If a batch ultimately fails a test, it must be stored in a separate and secure area, with a label indicating it failed a test.

OAR 333-333-7150

A manufacturer may order testing for quality control or research and development, but not for pesticide testing. Quality control or research and development testing are not subject to the pass/fail requirements above. However, a product tested in such a manner may not be sold. Manufacturers must keep the test results for two years.

Invitation for public comment

Do you have an opinion about any of these rules? The above rules are open for public comment from April 1, to April 22, 2022. You can find more information on how to comment here.

Look out for part three in this series, where we will discuss rules for psilocybin service training programs.

The post Oregon Psilocybin Draft Rules: Testing appeared first on Harris Bricken Sliwoski LLP.